Latest filing published 17 Dec 2025 for Dr. Lal Path Labs Ltd., €236. Read the official filing
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Manoj Kumar Garg on record concern Dr. Lal Path Labs Ltd., in the capacity of chief executive. The record holds 45 filings, for trades running from 18 May 2021 to 15 December 2025.
Every open-market trade on record is a sale: 27 sales worth €649k. Besides market trades, the filings include 18 share grants. So far in 2025, the count stands at no purchases and 2 sales.
Most recently, on 17 December 2025, the filings show a share grant worth €236 in Dr. Lal Path Labs Ltd. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations